Sartorius Aktiengesellschaft (SUVPF)
USD 224.0
(0.0%)
USD 224.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.31 Billion EUR | 109.01% |
| 2022 | 2.54 Billion EUR | 22.44% |
| 2021 | 2.07 Billion EUR | -0.55% |
| 2020 | 2.08 Billion EUR | 95.93% |
| 2019 | 1.06 Billion EUR | 6.03% |
| 2018 | 1 Billion EUR | 5.2% |
| 2017 | 954.97 Million EUR | 74.28% |
| 2016 | 547.93 Million EUR | 38.09% |
| 2015 | 396.78 Million EUR | 1.2% |
| 2014 | 392.07 Million EUR | -1.24% |
| 2013 | 397.01 Million EUR | 15.64% |
| 2012 | 343.32 Million EUR | 12.26% |
| 2011 | 305.81 Million EUR | 36.12% |
| 2010 | 224.67 Million EUR | -20.69% |
| 2009 | 283.28 Million EUR | 18.27% |
| 2008 | 239.51 Million EUR | 15.5% |
| 2007 | 207.36 Million EUR | 232.16% |
| 2006 | 62.43 Million EUR | -11.54% |
| 2005 | 70.57 Million EUR | -17.53% |
| 2004 | 85.58 Million EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.19 Billion EUR | -2.1% |
| 2024 Q3 | 4.35 Billion EUR | -2.13% |
| 2024 Q2 | 4.62 Billion EUR | -11.07% |
| 2023 Q2 | 2.77 Billion EUR | 6.48% |
| 2023 Q4 | 5.31 Billion EUR | -0.98% |
| 2023 Q3 | 5.36 Billion EUR | 93.4% |
| 2023 FY | 5.31 Billion EUR | 109.01% |
| 2023 Q1 | 2.6 Billion EUR | 2.49% |
| 2022 Q3 | 2.57 Billion EUR | 22.03% |
| 2022 Q2 | 2.11 Billion EUR | 2.63% |
| 2022 Q4 | 2.54 Billion EUR | -1.4% |
| 2022 Q1 | 2.05 Billion EUR | -0.86% |
| 2022 FY | 2.54 Billion EUR | 22.44% |
| 2021 Q3 | 2.12 Billion EUR | 0.27% |
| 2021 FY | 2.07 Billion EUR | -0.55% |
| 2021 Q2 | 2.12 Billion EUR | -2.81% |
| 2021 Q1 | 2.18 Billion EUR | 4.62% |
| 2021 Q4 | 2.07 Billion EUR | -2.46% |
| 2020 Q3 | 2.08 Billion EUR | 12.15% |
| 2020 FY | 2.08 Billion EUR | 95.93% |
| 2020 Q1 | 1.07 Billion EUR | 1.1% |
| 2020 Q2 | 1.86 Billion EUR | 72.74% |
| 2020 Q4 | 2.08 Billion EUR | 0.04% |
| 2019 FY | 1.06 Billion EUR | 6.03% |
| 2019 Q4 | 1.06 Billion EUR | -1.41% |
| 2019 Q3 | 1.08 Billion EUR | -0.92% |
| 2019 Q2 | 1.09 Billion EUR | 6.91% |
| 2019 Q1 | 1.01 Billion EUR | 1.52% |
| 2018 Q4 | 1 Billion EUR | -2.24% |
| 2018 Q2 | 1 Billion EUR | 3.76% |
| 2018 FY | 1 Billion EUR | 5.2% |
| 2018 Q1 | 969.9 Million EUR | 1.56% |
| 2018 Q3 | 1.02 Billion EUR | 2.11% |
| 2017 FY | 954.97 Million EUR | 74.28% |
| 2017 Q1 | 938.9 Million EUR | 71.35% |
| 2017 Q3 | 976.1 Million EUR | -1.62% |
| 2017 Q4 | 954.97 Million EUR | -2.16% |
| 2017 Q2 | 992.2 Million EUR | 5.68% |
| 2016 Q3 | 560.4 Million EUR | 0.07% |
| 2016 FY | 547.93 Million EUR | 38.09% |
| 2016 Q4 | 547.93 Million EUR | -2.22% |
| 2016 Q2 | 560 Million EUR | 35.66% |
| 2016 Q1 | 412.8 Million EUR | 4.04% |
| 2015 Q4 | 396.78 Million EUR | 7.82% |
| 2015 FY | 396.78 Million EUR | 1.2% |
| 2015 Q1 | 341.6 Million EUR | -12.87% |
| 2015 Q2 | 353.2 Million EUR | 3.4% |
| 2015 Q3 | 368 Million EUR | 4.19% |
| 2014 FY | 392.07 Million EUR | -1.24% |
| 2014 Q3 | 411.5 Million EUR | 0.07% |
| 2014 Q1 | 390.6 Million EUR | -1.62% |
| 2014 Q4 | 392.07 Million EUR | -4.72% |
| 2014 Q2 | 411.2 Million EUR | 5.27% |
| 2013 Q2 | 379 Million EUR | 6.85% |
| 2013 Q1 | 354.7 Million EUR | 3.31% |
| 2013 FY | 397.01 Million EUR | 15.64% |
| 2013 Q4 | 397.01 Million EUR | 8.44% |
| 2013 Q3 | 366.1 Million EUR | -3.4% |
| 2012 Q4 | 343.32 Million EUR | -2.02% |
| 2012 Q3 | 350.4 Million EUR | -2.99% |
| 2012 FY | 343.32 Million EUR | 12.26% |
| 2012 Q1 | 307.9 Million EUR | 0.68% |
| 2012 Q2 | 361.2 Million EUR | 17.31% |
| 2011 Q4 | 305.81 Million EUR | -4.01% |
| 2011 FY | 305.81 Million EUR | 36.12% |
| 2011 Q2 | 238 Million EUR | 5.87% |
| 2011 Q3 | 318.6 Million EUR | 33.87% |
| 2011 Q1 | 224.8 Million EUR | 0.06% |
| 2010 Q4 | 224.67 Million EUR | -11.16% |
| 2010 Q1 | 294 Million EUR | 3.78% |
| 2010 FY | 224.67 Million EUR | -20.69% |
| 2010 Q3 | 252.9 Million EUR | -6.71% |
| 2010 Q2 | 271.1 Million EUR | -7.79% |
| 2009 Q4 | 283.28 Million EUR | 0.0% |
| 2009 FY | 283.28 Million EUR | 18.27% |
| 2008 FY | 239.51 Million EUR | 15.5% |
| 2007 FY | 207.36 Million EUR | 232.16% |
| 2006 FY | 62.43 Million EUR | -11.54% |
| 2005 FY | 70.57 Million EUR | -17.53% |
| 2004 FY | 85.58 Million EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -1062160.0% |
| Ansell Limited | 855.59 Million USD | -520.772% |
| Ansell Limited | 857.2 Million USD | -519.61% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -23598.927% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -25370332.29% |
| Psykey, Inc. | 1.01 Million USD | -525459.074% |
| ConvaTec Group Plc | 1.31 Billion USD | -305.274% |
| ConvaTec Group Plc | 1.31 Billion USD | -304.701% |
| Encision Inc. | 1.33 Million USD | -398286.741% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -229954.182% |
| Innovative MedTech Inc. | 1.87 Million USD | -282682.947% |
| LifePoint, Inc. | 446.74 Thousand USD | -1188801.822% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -98363.493% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -242535.907% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -2188826.988% |
| SmileDirectClub, Inc. | 871.79 Million USD | -509.236% |
| Sector 10, Inc. | 164 Thousand USD | -3238497.561% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | -688.013% |
| SheerVision, Inc. | 75 Thousand USD | -7081633.333% |
| United Health Products, Inc. | 755.98 Thousand USD | -702463.133% |
| Vasamed, Inc. | 23.45 Thousand USD | -22649366.951% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -191825.908% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -671792.058% |